New Zealand to ban cough and cold meds for young children
This article was originally published in SRA
New Zealand’s drug regulatory agency, Medsafe, has accepted an expert committee’s recommendation that children under the age of six should not be given oral cough and cold medicines, with few exceptions1. While there is limited evidence that these medicines work in this age group, there have been reports of side effects.
You may also be interested in...
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.